Focus medication-assisted treatment of opioid addiction on people who have been incarcerated.
They can work, but pharma will need to master the intricacies of adherence metrics, real-world outcomes, and sampling.
Public opposition would be unseemly, so insurers and hospitals work behind the scenes against price transparency.
A nurse-focused program at Virginia Mason Medical Center in Seattle travels upstream to treat and prevent delirium, one of the main causes of falls in the hospital. The program was associated with a near halving of the delirium-related fall rate.
The check marks in this table show current health-reform bills cosponsored by 15 key senators.
In a last-minute filing, the attorney general elected not to defend the health care law. The legal arguments in Texas v. Azar hinge on severability and legislative intent.
Some heavy-hitting health care organizations think that the prior authorization process needs improvement, saying in a consensus statement that it “can be burdensome for all involved—health care providers, health plans, and patients. Yet, there is wide variation in medical practice and adherence to evidence-based treatment.”
“Medicare for All won’t work unless we get rid of fee-for-service medicine—period, end of sentence,” says Dean. “Otherwise you’re wasting your time.”
The “waste-free formulary” under development by the Pacific Business Group on Health sounds promising, but ultimately may not deliver the impact to self-insured employers its creators are promising. The approach glosses over a critical question: What constitutes “high-value”? The definition of value plays a central role in determining the care that patients ultimately receive.
For organizations with a good strategy to reduce care variation, a hospital efficiency improvement program can provide the jolt of incentive that generates real improvement.